Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_assertion type Assertion NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_head.
- NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_assertion wasGeneratedBy ECO_0000203 NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_provenance.
- NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_assertion wasDerivedFrom befree-20150227 NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_provenance.
- NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_assertion SIO_000772 23384775 NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_provenance.
- NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_assertion evidence source_evidence_literature NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_provenance.
- NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_assertion description "[Frequent outlier kinases in breast cancer included therapeutic targets like ERBB2 and FGFR4, distinct from MET, AKT2, and PLK2 in pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402231.RACWHct7XUy8P8YH8f-aYl77enGEZvlLAvFeFjF-e2mB8130_provenance.